Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy

    ... 1-risk (lower risk) myelodysplastic syndromes (MDS) and thrombocytopenia , but its long-term toxicity and efficacy are ... /l. The primary endpoint was adverse event (AE) incidence. Secondary endpoints were efficacy parameters, including bleeding events and ...

    Research Article last updated 07/11/2017 - 10:22am.

  2. 2018 Bone Marrow Failure Disease Scientific Symposium

    ... and Poster Session Friday, March 23 Biology of MDS and Secondary Acute Myeloid Leukemia Non-Transplant Treatments for MDS and ...

    Page last updated 02/15/2018 - 2:39pm.

  3. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    ... post-random assignment based on an intent-to-treat analysis. Secondary end points included relapse-free survival (RFS) and TRM. Results ... myelodysplastic syndromes (MDS) ...

    Research Article last updated 05/02/2017 - 10:29am.

  4. Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents

    ... and adolescents with primary myelodysplastic syndrome (MDS) and 82 cases with secondary MDS enrolled in two consecutive prospective studies of the ...

    Research Article last updated 04/29/2016 - 10:24am.

  5. Molecular features of early onset adult myelodysplastic syndrome

    ... with various subcategories of myelodysplastic syndrome and secondary acute myeloid leukemia, stratifying based on age at presentation and ... myelodysplastic syndromes (MDS) ...

    Research Article last updated 03/22/2017 - 10:52am.

  6. Recurrent and Secondary MDS

    Is MDS that returns after treatment(s) have successfully controlled it considered ... What is the difference between de novo MDS and secondary MDS ? De novo MDS refers to an MDS that has arisen without an ...

    Interview last updated 10/24/2012 - 1:12pm.

  7. Pediatric myelodysplastic syndromes: they do exist!

    ... malignancies in adults, myelodysplastic syndrome (MDS) is a heterogenous group of clonal disorders characterized by peripheral ... in ≥1 blood cell lineages. MDS frequently evolves to secondary acute myeloid leukemia with poor prognosis. Although uncommon among ...

    Research Article last updated 01/08/2014 - 9:02am.

  8. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry

    ... BACKGROUND: Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal stem cell disorders characterized by ... 40% of patients. Transfusion-dependent patients develop secondary iron overload . The influence of serum ferritin (SF) ...

    Research Article last updated 10/06/2016 - 1:01pm.

  9. What is Secondary MDS? Everything You Need to Know

    ... Treatment-related MDS, also known as secondary MDS , makes up a small fraction of cases of MDS. It is most ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  10. What is Secondary MDS? Everything You Need to Know

    ... Treatment-related MDS, also known as secondary MDS , makes up a small fraction of cases of MDS. It is ...

    LMS Item last updated 06/10/2016 - 1:24pm.